Healthcare -
Biotechnology - NASDAQ - US
$ 246.27
-1.16 %
$ 31.8 B
Market Cap
-94.0
P/E
ALNY - CHANGE IN WORKING CAPITAL
Change in Working Capital ALNY - Alnylam Pharmaceuticals, Inc.
10.8 M
LAST VALUE
43.74%
2 YEAR CAGR
-24.92%
5 YEAR CAGR
12.77%
10 YEAR CAGR